cmAngio® vs ClearRead CT
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary objective is to leverage routine mammography screenings to assess a woman's cardiovascular health risk. This tool is ideal for identifying Breast Arterial Calcifications (BAC) on both FFDM and DBT exams, providing crucial insights for early risk assessment without requiring additional radiation or procedures. It seamlessly integrates into existing breast imaging workflows to add a valuable layer of cardiovascular risk stratification.
View cmAngio® →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on enhancing the detection and characterization of pulmonary nodules and performing comprehensive coronary artery calcification (CAC) scoring using CT scans. This solution is best suited for improving diagnostic accuracy in lung cancer screening and detailed cardiothoracic assessments, offering advanced AI with patented vessel suppression and automated nodule tracking to streamline radiology workflows. It provides detailed nodule characterization and CAC scoring from ungated, non-contrast CTs.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | ClearRead CT |
|---|---|---|
| Pricing | Paid, out-of-pocket | Contact for pricing |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT emphasizes seamless PACS integration and vendor-neutral processing, which are critical for smooth workflow adoption in radiology departments. Studies also highlight its ability to significantly reduce reading times for radiologists, directly improving workflow efficiency. While cmAngio offers quick installation and DICOM compatibility, ClearRead CT's proven impact on reading efficiency and broad integration capabilities give it an edge.
Clinical Value
ClearRead CTClearRead CT demonstrates a broader clinical impact by enhancing both pulmonary nodule detection and coronary artery calcification analysis, with a reported 29% reduction in missed actionable nodules and improved detection of small nodules. Its CAC scoring shows high agreement with ground truth and enables opportunistic screening for cardiovascular disease. While cmAngio offers innovative cardiovascular risk assessment from mammograms, ClearRead CT provides more comprehensive and quantifiable improvements across multiple critical cardiothoracic conditions.
Pricing & Value
cmAngio®Both tools have opaque pricing, requiring direct vendor contact. However, cmAngio explicitly mentions 'limited-time offers for no-cost implementation and service' for its AI-based mammography solutions. This potential for no-cost initial adoption provides a tangible value advantage over ClearRead CT, for which no such offers were identified.
Enterprise Readiness
ClearRead CTClearRead CT offers superior enterprise readiness with both on-premise and cloud deployment options, providing greater flexibility for diverse IT infrastructures [JSON]. It also explicitly highlights seamless PACS integration, vendor-neutral processing, and availability on major AI platforms and PACS marketplaces. Its ISO27001 certification and deployment within the VA system further underscore its robust enterprise capabilities.
Innovation
TieBoth tools demonstrate significant innovation. cmAngio is innovative in its novel application of AI to mammograms for cardiovascular risk assessment, repurposing existing imaging data for a new diagnostic insight. ClearRead CT showcases innovation through its patented vessel suppression technology and automated nodule tracking, which significantly enhance the accuracy and efficiency of existing CT diagnostics [JSON, 5, 12, 27, 34]. Each brings a distinct and valuable innovative approach to medical imaging.
Support & Docs
ClearRead CTClearRead CT provides clear and comprehensive support resources, including a dedicated support page with contact information (email, phone, hours), an FAQ section, and accessible manuals and documentation. In contrast, cmAngio's provided information and search results do not detail specific support channels or documentation availability.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | ClearRead CT |
|---|---|---|
| Product Name | cmAngiou00ae | ClearRead CT |
| Company | CureMetrix | RIVERAIN TECHNOLOGIES |
| Description | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology. |
| Key Features | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard; Enables BAC identification and reporting without additional radiation or procedures; Compatible with any DICOM-compliant viewer; Adjustable operating point to meet clinical goals; Quick and easy installation (less than an hour); Cybersecure and HIPAA-compliant | Pulmonary Nodule Detection (solid, part-solid, ground glass); Patented Vessel Suppression (Clear Visual Intelligence); Nodule Characterization and Measurement (volume, diameter, location, type, depth); Automated Nodule Tracking and Comparison to Prior Exams; Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs); Reduced Reading Time (up to 36%); Improved Detection Accuracy (29% reduction in missed actionable nodules); Seamless PACS Integration / Vendor-neutral processing |
| Categories | Cardiology AI, OB/GYN AI, Radiology & Imaging AI | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Specialties | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and ClearRead CT.